7 results
A Controlled Trial of Erenumab for Episodic Migraine #EBM #Neuro #Erenumab #Migraine #CGRP #VisualAbstract #NEJM
Episodic Migraine #EBM ... #Neuro #Erenumab ... #Migraine #CGRP ... VisualAbstract #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP ... AdverseEvents #NEJM ... #NEJM
Pneumonia Severity Index (PSI) as a site-of-care tool. BUN, blood urea nitrogen; CHF, chronic heart failure;
Severity Index (PSI ... BUN, blood urea ... pressure #Management #EM ... #IM #Pneumonia ... Stratification #PSI
Pneumonia Severity Index (PSI) as a site-of-care tool. BUN, blood urea nitrogen; CHF, chronic heart failure;
Severity Index (PSI ... BUN, blood urea ... pressure #Management #EM ... #IM #Pneumonia ... Stratification #PSI
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation (RE-DUAL PCI trial) - Shown is
Dabigatran after PCI ... warfarin (Panel A) #EBM ... #Cardiology #IM ... TripleTherapy #PCI ... AtrialFibrillation #NEJM